Insider buying
~$30K39K sh @ $0.7712
Traded Jan 22, 2025 · filed 1 day later
The CEO of Cosmos Health paid $30K out of pocket for Cosmos Health shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 20, 2024 · Filed Dec 26, 2024
The CEO of Cosmos Health paid $150K out of pocket for Cosmos Health shares. 1 other person at Cosmos Health bought some too, in the same month. Shares held went up 7% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$150,000
Shares × reported transaction price
$100K–$500K
+7.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.0% | −0.5% | +3.5% |
| 30 days | +16.4% | +0.7% | +15.6% |
| 90 days | −29.7% | −4.7% | −25.0% |
| 180 days | −35.9% | +2.0% | −38.0% |
| 365 days | −27.6% | +15.6% | −43.2% |
Past results only. Not a forecast.
Insider buying
Traded Jan 22, 2025 · filed 1 day later
The CEO of Cosmos Health paid $30K out of pocket for Cosmos Health shares.
Insider buying
Traded Jan 17, 2025 · filed 4 days later
The CEO of Cosmos Health paid $25K out of pocket for Cosmos Health shares. 1 other person at Cosmos Health bought some too, in the same month.
Insider buying
Traded Jan 16, 2025 · filed 1 day later
The CEO of Cosmos Health paid $40K out of pocket for Cosmos Health shares. 1 other person at Cosmos Health bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Grigorios Siokas, Chief Executive Officer's past purchases, 90 days after disclosure: 40 buys, median −27.6 pts vs S&P 500, beat it 13 of 40 times. Past results, not a forecast.